Diabetic Ketoacidosis

What Is Diabetic Ketoacidosis?

Diabetic ketoacidosis, usually shortened to DKA, is an acute complication of diabetes in which the body runs short of effective insulin, begins breaking down fat for energy and floods the bloodstream with acidic substances called ketones. As those ketones accumulate, the blood becomes too acidic, dehydration deepens and essential minerals such as potassium shift to unsafe levels. It occurs most often in people with type 1 diabetes, but it can also develop in type 2 diabetes during severe illness — and in people who do not yet know they have diabetes at all.

Diabetic ketoacidosis is a medical emergency. It is also, in most people, a reversible one. Hospital treatment corrects dehydration, switches off ketone production, restores insulin activity, rebalances electrolytes and identifies whatever triggered the crisis in the first place. Depending on severity, care takes place in an emergency department, a monitored hospital ward or an intensive care unit.

What makes diabetic ketoacidosis deceptive is how ordinary its early stage can feel. Thirst, tiredness, nausea and stomach discomfort are easy to blame on a virus or something eaten. Blood glucose readings are often very high, but not always: DKA can develop at moderate glucose levels in certain circumstances, including with some diabetes medications, during pregnancy and after prolonged fasting or illness. That is why symptoms and ketone testing carry the diagnosis, not glucose readings alone.

What are ketones?

Ketones are acidic chemicals the liver produces when it breaks down fat for fuel instead of glucose. In small amounts they are normal — the body makes them during fasting, prolonged exercise or a low-carbohydrate diet, and clears them without difficulty. The problem in diabetes is scale and control. Without enough insulin, cells cannot take up glucose, so the body behaves as though it is starving and produces ketones far faster than it can clear them. The main ketone measured in hospital blood tests is beta-hydroxybutyrate. Another, acetone, is exhaled through the lungs and gives some patients the characteristic fruity-smelling breath of advanced DKA. Nutritional ketosis and ketoacidosis are therefore not the same thing: one is a controlled metabolic state, the other an uncontrolled acid load the body can no longer compensate for.

How does ketoacidosis develop?

Ketoacidosis develops when insulin levels fall too low to keep the body’s metabolism in balance, and each part of the resulting disturbance makes the others worse. The liver releases more glucose. The kidneys work to excrete the excess, dragging large volumes of water and electrolytes out with it, which drives dehydration. Fat breakdown accelerates, ketone levels climb and blood acidity rises. Stress hormones such as cortisol and adrenaline surge in response, pushing glucose and ketone production higher still. Vomiting often follows, cutting off the fluid intake that might otherwise compensate. Depending on the cause, this spiral can play out over a day or two — or, when insulin delivery stops abruptly, within hours.

What is the most common cause of DKA?

The most common causes of DKA are infection and missed or interrupted insulin. An infection — urinary, chest, gastrointestinal or a severe viral illness — raises the body’s insulin needs at exactly the moment appetite and routine are disrupted, so a dose that is normally adequate no longer is. Interrupted insulin covers a wide range of situations: forgotten or skipped doses, a blocked or dislodged insulin pump cannula, running out of supplies, or deliberately reduced doses because of illness, difficulty obtaining medication or fear of hypoglycaemia. Other recognised triggers include newly diagnosed diabetes, heart attack, stroke, pancreatitis, major trauma or surgery, corticosteroid therapy, heavy alcohol intake, certain glucose-lowering medications, severe emotional stress and the metabolic changes of pregnancy. Identifying the trigger is part of treatment, because correcting the blood chemistry without addressing the cause leaves the door open to recurrence.

Diabetic Ketoacidosis Symptoms

Diabetic ketoacidosis symptoms usually build over hours to a few days, and they follow the underlying chemistry: first the signs of high glucose and fluid loss, then the signs of acid build-up. Early on, most people notice intense thirst, frequent urination, a dry mouth, fatigue and weakness. Nausea, vomiting, abdominal pain, headache, blurred vision and unexplained weight loss commonly follow as the metabolic disturbance deepens.

As acidosis worsens, the body tries to blow off acid through the lungs, so breathing becomes deep, rapid or sighing — a pattern clinicians call Kussmaul breathing. Some patients develop fruity-smelling breath from acetone. In more advanced DKA, confusion, drowsiness, fainting or reduced consciousness can occur. Abdominal pain in DKA can be severe enough to imitate a surgical emergency, which is one reason laboratory testing rather than symptom pattern alone settles the diagnosis.

What are the warning signs of diabetic ketoacidosis?

The warning signs that separate ordinary high glucose from developing diabetic ketoacidosis are persistent vomiting, moderate or high ketone readings, deep or laboured breathing, fruity breath, marked drowsiness or confusion, severe weakness, and blood glucose that stays elevated despite correction insulin. These features indicate that the body is losing the ability to compensate and that hospital-level assessment and monitoring are what the situation now requires. Home glucose meters and ketone strips are valuable precisely because they can pick up this shift before breathing or consciousness changes — a rising ketone trend during illness is meaningful even while the person still feels only moderately unwell. Attempting to correct moderate or severe DKA at home with repeated insulin doses alone does not address the dehydration and electrolyte disturbance driving the crisis.

DKA symptoms in children, during pregnancy and in older adults

DKA symptoms do not look the same at every age or in every situation. In children and adolescents, DKA is often the first presentation of type 1 diabetes: weeks of thirst, weight loss and new bedwetting culminate in vomiting, abdominal pain and rapid breathing that families may initially read as a stomach bug. Children are also more vulnerable to fluid shifts during treatment, so paediatric protocols include close neurological monitoring throughout. In pregnancy, DKA can develop faster and at lower glucose levels than usual, because pregnancy itself changes how the body handles insulin and ketones; treatment has to consider both maternal stability and the baby’s well-being. In older adults, thirst signals are blunted, other conditions and medications can mask or mimic symptoms, and infection is a frequent trigger — so the presentation can be quieter while the physiological reserve is smaller.

Who Develops DKA and How It Is Diagnosed

Anyone with diabetes can develop DKA, but the risk is not evenly distributed. People with type 1 diabetes depend on injected or pumped insulin for survival, so any interruption in delivery matters within hours. People with type 2 diabetes usually retain some insulin production, but severe illness, infection, trauma, surgery or certain medications can overwhelm it. Some adults initially labelled as having type 2 diabetes turn out to have significant insulin deficiency, and their first DKA admission is what prompts a reassessment of the diagnosis itself. A substantial group of patients — children and young adults especially — meet DKA before they meet diabetes: the emergency is the moment the condition is discovered.

Diagnosis combines clinical assessment with urgent laboratory testing. Blood tests measure glucose, ketones or beta-hydroxybutyrate directly, blood acidity, bicarbonate, electrolytes and kidney function, along with markers of infection or inflammation where relevant. A venous or arterial blood gas quantifies the acidosis. Urine testing may show ketones, though blood ketone measurement gives more direct information in most settings. An electrocardiogram is performed when potassium disturbance is suspected or the patient has chest pain, palpitations or cardiovascular risk factors. Because dehydration is a major driver of instability, treatment usually begins while some of these results are still pending.

Finding the trigger runs in parallel. Depending on the clinical picture, this can mean blood and urine cultures, chest imaging for suspected pneumonia, cardiac testing if a heart event is possible, abdominal imaging when pain is severe, pregnancy testing where relevant, and a practical review of insulin pump function, infusion sites and injection technique. None of this delays the core treatment; it shapes what happens alongside it.

Can DKA happen when blood glucose is not very high?

Yes — this is called euglycemic DKA, and it is one of the most easily missed forms of the condition. Ketones and acidosis are present, but glucose is only modestly elevated or close to normal, so a glucose reading on its own is falsely reassuring. Euglycemic DKA is associated with sodium-glucose cotransporter-2 (SGLT2) medications, pregnancy, prolonged fasting, heavy alcohol intake and reduced carbohydrate intake combined with illness or surgery. In these situations, symptoms and ketone testing carry the diagnosis: feeling significantly unwell despite unremarkable glucose readings is still a finding that deserves proper laboratory assessment.

Conditions and Situations DKA Treatment Addresses

DKA treatment addresses the immediate metabolic crisis and the clinical situations that commonly cause or worsen it. The core condition is severe insulin deficiency with ketone accumulation and metabolic acidosis. Without enough insulin, the liver releases more glucose while the body produces ketones faster than the kidneys and lungs can clear them. Treatment interrupts this cycle at several points at once and allows normal metabolism to resume.

The most common setting is type 1 diabetes with missed insulin, delayed diagnosis, intercurrent illness or insulin pump failure. Pump users deserve particular mention: because pumps deliver only rapid-acting insulin, which leaves the body quickly, even a short unnoticed interruption — a kinked cannula, a dislodged infusion set, an empty reservoir — can start ketone formation within hours. A pump user can therefore develop DKA without a long preceding period of very high glucose, which is why unexplained rising readings on a pump prompt a check of the hardware, not just a correction dose.

In type 2 diabetes, DKA tends to appear under major physiological stress: infection, surgery, heart attack, stroke, pancreatitis or serious injury. Some patients with type 2 diabetes pass through periods of significant insulin deficiency and present with DKA at first diagnosis. For this group, treatment has two layers — emergency stabilisation now, and a later reassessment of the diabetes type, medication plan and monitoring strategy so the same gap does not open again.

Paediatric, obstetric and geriatric presentations each change the treatment calculus. Children and adolescents may arrive with new-onset diabetes, dehydration, abdominal pain, vomiting or rapid breathing, and need carefully calculated fluids with close neurological observation. In pregnancy, DKA can develop at lower glucose levels and progress quickly, so maternal stabilisation and fetal monitoring proceed together. In older adults, kidney function, heart disease, medication interactions and infection risk all influence how fluids and insulin are given and how fast.

Beyond these, DKA treatment is relevant to episodes associated with steroid therapy, cancer treatment, severe infection, eating disorders, alcohol-related illness, reduced food intake and lack of reliable access to insulin. Travel adds its own practical layer: time-zone changes that scramble dosing schedules, heat exposure that degrades insulin, disrupted routines, gastrointestinal illness abroad and problems transporting supplies can all raise the risk. A realistic discharge plan takes these everyday factors into account rather than assuming ideal conditions.

How to Treat Diabetic Ketoacidosis

Diabetic ketoacidosis is treated in hospital with a structured protocol that corrects four problems at the same time: dehydration, insulin deficiency, ketone-driven acidosis and electrolyte imbalance. Each element supports the others — fluids restore circulation and help the kidneys clear ketones, insulin switches off ketone production, electrolyte replacement protects the heart and nervous system, and frequent monitoring steers every adjustment. A typical protocol unfolds in the following sequence.

• Step 1 — Assessment and stabilisation. The team checks airway, breathing, circulation, level of consciousness, hydration and vital signs, and screens for shock, infection, chest pain, pregnancy and neurological symptoms. Blood and urine tests are ordered urgently. The patient’s diabetes history, insulin regimen, medications, allergies, kidney and heart status and any pump or sensor use are reviewed — and where records are unavailable, treatment proceeds on emergency findings alone.
• Step 2 — Intravenous fluid replacement. Controlled IV fluids are usually the first active treatment, often started before all laboratory results return. The type and rate are chosen according to blood pressure, heart rate, sodium level, kidney function, age and cardiac status. Fluids restore blood volume, improve circulation and support the kidneys in clearing glucose and ketones.
• Step 3 — Insulin infusion. In moderate to severe DKA, insulin is delivered through a continuous intravenous infusion because it can be adjusted precisely. Its most important job is not lowering glucose but switching off ketone production so the acid-base balance can recover.
• Step 4 — Electrolyte replacement. Potassium is checked frequently and replaced when needed; sodium, phosphate, magnesium and bicarbonate status are assessed according to the clinical picture. If potassium is low at the outset, insulin may be briefly delayed while it is corrected.
• Step 5 — Continuous monitoring. Repeated glucose checks, ketone or beta-hydroxybutyrate measurements, electrolyte panels, kidney function tests, blood gas analysis, urine output monitoring and cardiac rhythm observation track the direction and speed of change, which matter more than any single number.
• Step 6 — Treating the trigger. Infection is treated, a failed pump is investigated, a cardiac or abdominal cause is managed by the relevant specialty. DKA corrected without its cause addressed tends to come back.
• Step 7 — Transition to subcutaneous insulin. Once DKA has resolved by laboratory criteria and the patient can eat and drink, long-acting insulin is given with an appropriate overlap before the infusion stops, so insulin levels never fall abruptly and ketone production does not restart.

Several details inside this sequence deserve unpacking. The first is what happens to the fluids as treatment progresses: as glucose falls, the fluid composition is usually adjusted to include dextrose. This looks counterintuitive — giving sugar to someone admitted with high sugar — but it allows the insulin infusion to continue safely until ketones clear and acidosis resolves, because glucose typically normalises before the acid disturbance does. Stopping insulin at the moment glucose looks acceptable, while ketones are still present, allows the acidosis to return.

The second is the potassium paradox. At presentation, blood potassium may read normal or even high, while the body’s total potassium stores are actually depleted — acidosis and insulin deficiency shift potassium out of cells into the bloodstream, masking the deficit. As fluids and insulin take effect, potassium moves back into cells and blood levels can fall quickly. Too low, and dangerous heart rhythm problems or muscle weakness can follow. This is why potassium is measured repeatedly, replaced proactively and interpreted as a trend rather than a snapshot, and why DKA belongs in a setting with rapid laboratory access.

The third is what is deliberately not done routinely. Bicarbonate, which might seem the obvious answer to acid blood, is not part of standard treatment; it is generally reserved for severe acidosis under specialist supervision, because the body corrects its own acid-base balance once ketone production stops. Phosphate and magnesium are replaced selectively, when levels are significantly low or symptoms are present, rather than by default.

Technology supports each step without replacing judgement. Rapid laboratory platforms turn around electrolytes, blood gases, ketones and kidney function quickly enough to guide hourly decisions. Bedside glucose testing allows frequent insulin adjustments. Cardiac monitoring can catch rhythm changes related to potassium shifts. Imaging and microbiology help identify infection or another trigger. For patients using pumps or continuous glucose monitors, device data can reveal exactly when insulin delivery failed — useful context, though hospital decisions rest on validated measurements and direct assessment.

How long does DKA treatment take in hospital?

Most patients need close monitoring for at least several hours, and hospital admission is common. Mild DKA may resolve within a shorter observation period with fluids, insulin and monitoring. Severe acidosis, significant electrolyte disturbance, infection, kidney impairment, pregnancy, paediatric presentations or altered consciousness usually mean a monitored unit or intensive care and a longer stay. Discharge is not driven by the clock but by criteria: the patient can drink and eat, can take insulin safely, understands the follow-up plan, and the underlying trigger has been addressed.

Is diabetic ketoacidosis curable?

The episode of diabetic ketoacidosis itself resolves with treatment — ketones clear, acidosis corrects and blood chemistry returns to normal, and in that sense most people come through DKA without lasting damage. What treatment does not change is the underlying diabetes, which continues and requires ongoing insulin and management. It is more accurate to say DKA is reversible and preventable than curable: the emergency ends, and the work shifts to making sure the conditions that produced it do not recur.

How long can you survive with diabetic ketoacidosis?

There is no reliable countdown, and it would be misleading to give one. Untreated DKA worsens progressively — over days in a slowly evolving case, over hours when insulin delivery has stopped completely, when the trigger is severe, or in children and during pregnancy — and it becomes life-threatening as dehydration, acidosis and potassium disturbance deepen. What the question really points to is the reason DKA is classified as an emergency: the condition does not stabilise on its own, because vomiting and fluid loss steadily remove the body’s ability to compensate. With hospital treatment started in time, the picture reverses: most people respond well to protocol-based care and the metabolic crisis resolves.

Why Acting Early Matters

Early treatment matters because DKA is self-accelerating. Dehydration reduces the kidneys’ ability to clear glucose and ketones, while acidosis affects the brain, heart, circulation and breathing. As vomiting and fluid loss continue, drinking enough to compensate becomes impossible, and stress hormones keep pushing glucose and ketone production upward. Electrolyte disturbances can deepen during both the illness and its treatment if not monitored carefully.

Delay raises the stakes on several fronts at once: shock, kidney injury, severe potassium abnormalities, abnormal heart rhythms, aspiration from vomiting, reduced consciousness and, in rare severe cases, brain swelling. Children, pregnant patients, older adults and people with infection or cardiovascular disease are the most vulnerable groups. A patient who looks only mildly unwell at home can deteriorate while ketones continue to rise — appearance lags chemistry in DKA.

Acting early also shortens the whole illness. DKA recognised before severe acidosis or profound dehydration develops usually needs less intensive treatment and recovers more smoothly. Early evaluation gives clinicians the chance to treat infection, correct insulin problems and prevent recurrence, rather than managing a full-blown crisis. For people who are travelling, early assessment keeps a manageable problem from becoming a complicated one far from home.

Sick-day awareness sits at the centre of this. Home glucose and ketone testing during illness exists precisely to catch the early phase, when the trend is visible but the body is still compensating. Once persistent vomiting, high ketones, deep breathing, confusion or severe weakness appear, the situation has moved beyond what home measures address, and laboratory monitoring is what safe treatment requires.

Benefits of Diabetic Ketoacidosis Treatment

The benefits of DKA treatment come from rapid stabilisation, careful monitoring and correction of the underlying metabolic imbalance — plus the less visible benefit of leaving hospital with a clearer plan than the one that preceded the admission.

Benefit	What It Means for You
Correction of dehydration	IV fluids restore circulation, support kidney function, and help the body clear excess glucose and ketones more effectively.
Reduction of ketone production	Insulin therapy stops the process that creates acid buildup, allowing blood chemistry and breathing patterns to normalise.
Electrolyte stabilisation	Frequent testing and replacement help protect the heart, muscles, and nervous system during treatment.
Treatment of the trigger	Identifying infection, insulin interruption, medication effects, or other causes reduces the risk of the same crisis recurring.
Safer long-term diabetes planning	Before discharge, the care team can refine insulin dosing, sick-day rules, ketone testing, and follow-up recommendations.

Recovery Timeline After Diabetic Ketoacidosis

Recovery depends on the severity of the episode, the trigger and the patient’s overall health, but most people follow a monitored progression from emergency stabilisation through to discharge planning and outpatient follow-up.

Time Period	What Patients Can Expect
Day 1	Emergency assessment, IV fluids, insulin therapy, electrolyte monitoring, blood tests, and investigation of the cause. Some patients are treated in a monitored unit or intensive care setting.
First Week	Fatigue may continue as hydration and appetite recover. Insulin doses may be adjusted, and any infection or underlying illness is treated. Follow-up instructions are reviewed carefully.
First Month	Endocrinology follow-up focuses on glucose patterns, ketone prevention, insulin technique or pump settings, medication review, and education for sick days and travel.
Longer Term	The goal is to reduce recurrence risk through a personalised diabetes plan, reliable access to insulin and supplies, and clear guidance for illness, fasting, exercise, and travel.

How long does it take to recover from diabetic ketoacidosis?

The blood chemistry usually corrects within the first day or so of treatment, but feeling well again takes longer. Most people notice fatigue for several days after discharge, because dehydration, acidosis, any infection and disturbed sleep each take their own time to settle. Appetite typically returns gradually. Recovery is slower when the trigger was significant — pneumonia, pancreatitis or a cardiac event keeps the body under stress after the DKA itself has resolved — and when the episode was a first diagnosis of diabetes, since the early weeks then also involve absorbing a new routine of injections, monitoring and education. Endocrinology follow-up in the first weeks is where doses are fine-tuned and the prevention plan takes its final shape.

What Influences Outcomes and a Good Result

Outcomes in DKA are shaped most strongly by two things: how early treatment begins and how severe the metabolic disturbance is at presentation. Patients who receive prompt fluids, insulin, electrolyte correction and monitoring generally recover well, particularly when the trigger is identified and treated. Delayed presentation, severe infection, kidney injury, pregnancy, very young or older age and significant cardiovascular disease each add complexity — not impossibility, but more moving parts to manage at once.

A good result is not defined by a glucose number. DKA has resolved when ketones have cleared, acidosis has corrected, electrolytes are stable, the patient can eat and drink, and a safe insulin plan is in place. Glucose often improves before the acidosis has fully resolved, which is exactly why insulin treatment continues with dextrose-containing fluids past the point where the meter looks reassuring. Stopping insulin too early allows ketones to return, and a relapse inside the same admission is a worse outcome than a slightly longer infusion.

Potassium management is one of the biggest single safety factors. Because potassium shifts during the illness and again during treatment, clinicians respond to trends rather than isolated values; overcorrection and undercorrection are both dangerous, and kidney function and urine output guide every replacement decision. This is the practical argument for treating DKA where rapid laboratory turnaround and clinicians experienced in metabolic emergencies are available.

The cause of the episode shapes the recovery just as much as the chemistry. A patient whose DKA followed a missed insulin dose may stabilise quickly once insulin is restored and the gap in routine is understood. A patient with pneumonia, pancreatitis, a heart event or severe vomiting needs longer, because the body remains under stress after the acidosis clears. In newly diagnosed diabetes, the first DKA admission is also the first chapter of long-term diabetes education, which takes time, clarity and — where appropriate — family involvement.

Education after the event has a measurable effect on future risk. The topics that matter most are checking ketones during illness or persistent high glucose, understanding why basal insulin continues even when eating is difficult, using correction insulin as agreed with the treating team, staying hydrated, recognising pump infusion problems early, carrying backup insulin and supplies, and knowing which warning signs mean the situation has moved beyond home management. An episode of DKA is also a sensible moment to look at diabetes care as a whole, because the same control gaps that produce ketone crises also drive long-term complications such as diabetic retinopathy and diabetic nephropathy — one admission can prompt a review that protects eyes and kidneys years down the line.

Finally, communication matters more than it might seem. Patients and families need to understand what happened and what to do differently, and that conversation only works if it is honest in both directions. For many people, DKA arrives during a stressful illness or life event, not through lack of effort. A nonjudgmental approach makes it possible to surface the practical barriers — medication access, cost pressures, fear of hypoglycaemia, eating difficulties, shift work, uncertainty about sick-day dosing — that written instructions alone never reach. Addressing those barriers is part of the outcome, not an afterthought to it.

How to Manage Diabetic Ketoacidosis Risk Long Term

Managing diabetic ketoacidosis over the long term means preventing the next episode, and prevention is mostly about closing the specific gap that caused this one. If the trigger was infection, the plan centres on sick-day preparedness: knowing that illness raises insulin requirements even when food intake falls, and having an agreed approach — worked out in advance with the treating team — for how monitoring and dosing are handled on days when eating is difficult. If the trigger was a pump interruption, the plan centres on hardware: routine checks of infusion sites and reservoirs, alarms taken seriously, and backup injection supplies kept within reach so that a device failure never becomes an insulin gap.

Ketone testing deserves its own habit. Blood or urine ketone checks during any significant illness, and whenever glucose stays unexpectedly high, catch the early phase of ketone build-up while it is still a trend rather than a crisis. People taking SGLT2 medications, and anyone who has had euglycemic DKA, have a particular reason to test ketones on symptoms rather than waiting for a high glucose reading, since their glucose may not flag the problem.

Travel planning reduces a cluster of avoidable risks: insulin stored away from heat, supplies split across bags in case one is lost, prescriptions and a brief medical summary carried in hand luggage, and dosing schedules thought through before crossing time zones rather than improvised mid-flight. Routine follow-up with an endocrinologist keeps the whole plan current — doses drift, devices change, life circumstances shift, and a regimen that fitted last year may be the quiet setup for next year’s admission if it is never revisited.

None of this asks for perfection. It asks for a small number of reliable habits — ketone strips that are in date, a sick-day plan that exists on paper, a backup insulin pen that is actually in the bag — that together remove most of the common paths back to the emergency department.

Diabetic Ketoacidosis Care at Acibadem

At Acibadem, diabetic ketoacidosis is treated as what it is: a time-sensitive and detail-sensitive metabolic emergency. The same patient may need fluid resuscitation, an insulin infusion, potassium replacement, infection work-up, cardiac monitoring and a medication review within a short window, so DKA care is organised around coordination — emergency physicians begin stabilisation while endocrinology, intensive care, internal medicine, paediatrics, obstetrics, cardiology or infectious diseases specialists are brought in as the individual case demands. Treatment follows established international protocols, adapted to the patient’s age, diabetes type, comorbidities and severity.

The hospital environment supports the pace this condition sets: rapid laboratory testing for electrolytes, blood gases and ketones, monitored care areas, bedside glucose testing, cardiac rhythm monitoring and imaging when a trigger needs to be found. For patients using insulin pumps or glucose sensors, device data is reviewed for context, while treatment decisions remain grounded in hospital measurements and direct clinical assessment.

Multidisciplinary input matters most when DKA is not an isolated event. Where infection is present, infectious disease specialists guide antimicrobial choices. Where pregnancy is involved, obstetric and endocrine teams manage maternal and fetal considerations together. Where the episode traces back to a cardiac event, pancreatitis, kidney disease or a medication effect, the relevant specialty joins the plan. For children and adolescents, paediatric teams handle fluid management, neurological monitoring and family education in an age-appropriate way.

Care does not end when the infusion stops. Before discharge, an endocrinologist reviews whether the insulin regimen should change, whether pump or sensor settings need adjustment, whether the type of diabetes should be reassessed and what education is still missing. Patients typically leave with a written plan covering sick days, ketone testing, correction dosing, hydration, travel and follow-up, along with documentation prepared for the physician who will continue their care — so that what was learned in hospital travels with the patient rather than staying behind in the file.